ACADIA Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
ACADIA Pharmicals宣佈,用於治療雷特綜合徵的Trofinetide新藥已被加拿大衛生部接受申請和優先審查
ACADIA Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
ACADIA Pharmicals宣佈,用於治療雷特綜合徵的Trofinetide新藥已被加拿大衛生部接受申請和優先審查
使用瀏覽器的分享功能,分享給你的好友吧